|
|
Changes of serum cystatin C in patients with rheumatoid arthritis and its significance |
GAO Deng-wen YU Shao-hui ZHAO Dong |
Department of Nephropathy Rheumatology,People′s Hospital of Macheng City in Hubei Province,Macheng 438300, China |
|
|
Abstract Objective To explore the change of serum cystatin C(CysC)in patients with rheumatoid arthritis(RA)and its clinical significance.Methods 70 patients with RA were selected as observation group and 70 cases of healthy check-up were selected as control group in People′s Hospital of Macheng City from June 2015 to September 2016. CysC and serum creatinine(SCr)in two groups were detected by using an automatic biochemical analyzer.MDRD equation 7 was used to calculate creatinine clearance(CCr).The correlation between CysC and SCr,CCr,CRP,ESR,DAS28 was assessed respectively.After application of glucocorticoid combined with DMARDs for three months in 30 patients in the observation group (DAS28≥3.2),CysC and some other parameters were again detected and analyzed.Results The Cystatin C level in the observation group was significantly higher than that of the control goup(P<0.01),while SCr and CCr showed no significant difference between two groups(P>0.05).In the observation group,CysC level was positively correlated with SCr,CRP,ESR,DAS28(r=0.297,P=0.014;r=0.321,P=0.008;r=0.566,P=0.000;r=0.383,P=0.000),and negatively correlated with CCr(r=-0.347,P=0.004).Compared with before treatment,the CysC,CRP,ESR,and DAS28 in active RA patients decreased significantly after treatment(P<0.01).Conclusion In patients with RA,cystatin C may be not only an indicator of early renal impairment but also a marker of disease activity.
|
|
|
|
|
[4] |
白姣,刘纯.胱抑素C在自身免疫性疾病中的作用[J].检验医学与临床,2016,13(7):993-995.
|
[1] |
Daoussis D,Panoulas VF,Antonopoulos I,et al.Cardiovascular risk factors and not disease activity,severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis[J].Ann Rheum Dis,2010,69(3):517-521.
|
[2] |
Prevoo ML,vant'Hof MA,Kuper HH,et al.Modified disease activity scores that include twenty eight joint counts:development and validation in a prospective longitudinal study of patients with rheumatoid arthritis[J].Arthritis Rheum,1995,38(1):44-48.
|
[3] |
Levey AS,Bosch JP,Lewis JB,et al.A more accurate method to estimate glomerular filtration rate from serum creatinine:a new prediction equation.Modification of Diet in Renal Disease Study Group[J].Ann Intern Med,1999,130(6):461-470.
|
[5] |
KellerCR,OddenMC,FriedLF,etal.Kidneyfunctionandmarkers of inflammation in elderly persons without chronic kidney disease:the health,aging,and body composition study[J]. Kidney Int,2007,71(3):239-244.
|
[6] |
Keller C,Katz R,Cushman M,et al.Association of kidney function with inflammatory and procoagulant markers in a diverse cohort:a cross-sectional analysis from the multi-ethnic study of atherosclerosis(MESA)[J].BMC Nephrol,2008,9:9.
|
[7] |
Lee BT,Ahmed FA,Hamm LL,et al.Association of C-reactive protein,tumor necrosis factor-alpha,and interleukin-6 with chronic kidney disease[J].BMC Nephrol,2015,16:77.
|
[8] |
Gupta J,Mitra N,Kanetsky PA,et al.Association between albuminuria,kidney function,and inflammatory biomarker profile in CKD in CRIC[J].Clin J Am Soc Nephrol,2012,7(12):1938-1946.
|
[9] |
Upadhyay A,Larson MG,Guo CY,et al.Inflammation,kidney function and albuminuria in the framingham off spring cohort[J].Nephrol Dial Transplant,2011,26(3):920-926.
|
[10] |
Shankar A,Sun L,Klein BE,et al.Markers of inflammation predict the long-term risk of developing chronic kidney disease:a population-based cohort study[J].Kidney Int,2011,80(11):1231-1238.
|
[11] |
Koseki Y,Terai C,Moriguchi M,et al.A prospective study of renal disease in patients with early rheumatoid arthritis[J]. Ann Rheum Dis,2001,60(4):327-331.
|
[12] |
Chiu HY,Huang HL,Li CH,et al.Increased risk of chronic kidney disease in rheumatoid arthritis associated with cardiovascular complications——a national population-based cohort study[J].PLoS One,2015,10(9):e0136508.
|
[13] |
Kim HW,Lee CK,Cha HS,et al.Effect of anti-tumor necrosis factor alpha treatment of rheumatoid arthritis and chronic kidney disease[J].Rheumatol Int,2015,35(4):727-734.
|
[14] |
Lertnawapan R,Bian A,Rho YH,et al.Cystatin C,renal function and atherosclerosis in rheumatoid arthritis[J].J Rheumatol,2011,38(11):2297-2300.
|
[15] |
Targońska-Stepniak B,Majdan M.Cystatin C concentration is correlated with disease activity in rheumatoid arthritis patients[J].Scand J Rheumatol,2011,40(5):341-346.
|
|
|
|